Evidence map›Paper›PMID 31377797›Full record

ArticleRheumatology (Oxford, England)2020

Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.

Pawel A Kabala, Beatriz Malvar-Fernández, Ana P Lopes, Tiago Carvalheiro, Sarita A Y Hartgring, Man Wai Tang, Carmen Conde, Dominique L Baeten, Matthew Sleeman, Paul P Tak and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Transcriptomic Analysis ofFrontiers in cellular and infection microbiology · 2021
    Article
  14. Article
  15. Frontiers in pharmacology · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 5 countries.

Pawel A KabalaDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Beatriz Malvar-FernándezDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Ana P LopesDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Tiago CarvalheiroDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Sarita A Y HartgringDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Man Wai TangDepartment of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands.
Carmen CondeLaboratorio de Investigación 8 y Servicio de Reumatología, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, Spain.
Dominique L BaetenDepartment of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands.
Matthew SleemanRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Paul P TakDepartment of Clinical Immunology and Rheumatology, University of Amsterdam, Amsterdam, The Netherlands.
Jane ConnorMedImmune LCC, MD, USA.
Timothy R RadstakeDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Kris A ReedquistDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Samuel GarcíaDepartment of Rheumatology and Clinical Immunology, University of Utrecht, Utrecht.
Utrecht University · NLUniversity of Amsterdam · NLInstituto de Investigación Sanitaria de Santiago · ESRegeneron (United States) · USUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the role of Tie2 signalling in macrophage activation within the context of the inflammatory synovial microenvironment present in patients with RA and PsA.

methodsClinical responses and macrophage function were examined in wild-type and Tie2-overexpressing (Tie2-TG) mice in the K/BxN serum transfer model of arthritis. Macrophages derived from peripheral blood monocytes from healthy donors, RA and PsA patients, and RA and PsA synovial tissue explants were stimulated with TNF (10 ng/ml), angiopoietin (Ang)-1 or Ang-2 (200 ng/ml), or incubated with an anti-Ang2 neutralizing antibody. mRNA and protein expression of inflammatory mediators was analysed by quantitative PCR, ELISA and Luminex.

resultsTie2-TG mice displayed more clinically severe arthritis than wild-type mice, accompanied by enhanced joint expression of IL6, IL12B, NOS2, CCL2 and CXCL10, and activation of bone marrow-derived macrophages in response to Ang-2 stimulation. Ang-1 and Ang-2 significantly enhanced TNF-induced expression of pro-inflammatory cytokines and chemokines in macrophages from healthy donors differentiated with RA and PsA SF and peripheral blood-derived macrophages from RA and PsA patients. Both Ang-1 and Ang-2 induced the production of IL-6, IL-12p40, IL-8 and CCL-3 in synovial tissue explants of RA and PsA patients, and Ang-2 neutralization suppressed the production of IL-6 and IL-8 in the synovial tissue of RA patients.

conclusionTie2 signalling enhances TNF-dependent activation of macrophages within the context of ongoing synovial inflammation in RA and PsA, and neutralization of Tie2 ligands might be a promising therapeutic target in the treatment of these diseases.

Indexed as

AnimalsArthritis, ExperimentalArthritis, PsoriaticArthritis, RheumatoidCytokinesHumansInflammationMacrophage ActivationMacrophagesMiceMice, TransgenicReceptor, TIE-2Signal TransductionSynovial FluidSynovial MembraneCytokinesReceptor, TIE-2TEK protein, humanangiopoietinsinflammationmacrophagespsoriatic arthritisrheumatoid arthritisserum transfer-induced arthritissynovial tissue explantsTie2

Identifiers

PMID31377797
PMCPMC7571483
OpenAlexW2966506863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.